ACADIA Pharmaceuticals
ACAD
#3189
Rank
$4.64 B
Marketcap
$27.44
Share price
3.35%
Change (1 day)
46.27%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.41 Billion USD

According to ACADIA Pharmaceuticals's latest financial reports the company's total liabilities are $0.41 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ACADIA Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.45 B43.43%
2023-12-31$0.31 B69.27%
2022-12-31$0.18 B17.69%
2021-12-31$0.15 B2.33%
2020-12-31$0.15 B85.14%
2019-12-31$84.04 M37.51%
2018-12-31$61.12 M24.18%
2017-12-31$49.22 M15.16%
2016-12-31$42.74 M93.11%
2015-12-31$22.13 M38.61%
2014-12-31$15.96 M128.55%
2013-12-31$6.98 M-70.4%
2012-12-31$23.6 M169.72%
2011-12-31$8.75 M0.53%
2010-12-31$8.7 M-76.82%
2009-12-31$37.56 M221.49%
2008-12-31$11.68 M-43.41%
2007-12-31$20.65 M-7.75%
2006-12-31$22.38 M-3.24%
2005-12-31$23.13 M138.87%
2004-12-31$9.68 M-88.52%
2003-12-31$84.36 M50.35%
2002-12-31$56.11 M1269.62%
2001-12-31$4.09 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vanda Pharmaceuticals
VNDA
$0.13 B-67.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$115.63 B 27,865.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$91.08 B 21,927.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$113.53 B 27,358.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$78.28 B 18,833.30%๐Ÿ‡บ๐Ÿ‡ธ USA